相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complement dependency of cardiomyocyte release of mediators during sepsis
Gelareh Atefi et al.
FASEB JOURNAL (2011)
Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice
Helga D. Manthey et al.
FASEB JOURNAL (2011)
l-Carnitine Attenuates Cardiac Remodelling rather than Vascular Remodelling in Deoxycorticosterone Acetate-Salt Hypertensive Rats
Daniel O'Brien et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats
Abishek Iyer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: Further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells
Ali Jalili et al.
EXPERIMENTAL HEMATOLOGY (2010)
Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart
Scott P. Levick et al.
HYPERTENSION (2009)
Complement factors C3a and C5a have distinct hemodynamic effects in the rat
Lavinia M. Proctor et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Complement component 5a (C5a)
Helga D. Manthey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease
Maria I. Fonseca et al.
JOURNAL OF IMMUNOLOGY (2009)
Role of complement C5a in mechanical inflammatory hypernociceptio: potential use of C5a receptor antagonists to control inflammatory pain
E. Ting et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Complement activation and cardiovascular disease
M. Bjerre et al.
HORMONE AND METABOLIC RESEARCH (2008)
The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis
Trent M. Woodruff et al.
JOURNAL OF IMMUNOLOGY (2008)
Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
Riina Oksjoki et al.
ATHEROSCLEROSIS (2007)
Function, structure and therapeutic potential of complement C5a receptors
P. N. Monk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Complement regulation in human atherosclerotic coronary lesions -: Immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway
Riina Oksjoki et al.
ATHEROSCLEROSIS (2007)
Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation
Scott P. Levick et al.
JOURNAL OF IMMUNOLOGY (2007)
C5aR-mediated myocardial ischemia/reperfusion injury
Haimou Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase
David Loch et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats
Vincent Chan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling
Qianli Yu et al.
HYPERTENSION (2006)
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Trent M. Woodruff et al.
FASEB JOURNAL (2006)
Myocardial proteases and matrix remodeling in inflammatory heart disease
S Rutschow et al.
CARDIOVASCULAR RESEARCH (2006)
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A(2) in young spontaneously hypertensive rats
Scott Levick et al.
JOURNAL OF IMMUNOLOGY (2006)
The role of complement in danger sensing and transmission
J Kohl
IMMUNOLOGIC RESEARCH (2006)
Production of IL-1β, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis
W Cao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
The extracellular matrix and inflammation -: Fibromodulin activates the classical pathway of complement by directly binding C1q
A Sjöberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A role for T lymphocytes in mediating cardiac diastolic function
QL Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
The role of the complement system in ischemia-reperfusion injury
TV Arumugam et al.
SHOCK (2004)
Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats
TM Woodruff et al.
JOURNAL OF SURGICAL RESEARCH (2004)
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease
TM Woodruff et al.
JOURNAL OF IMMUNOLOGY (2003)
A convergent solution-phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug
RC Reid et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat
TM Woodruff et al.
ARTHRITIS AND RHEUMATISM (2002)
Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine
TV Arumugam et al.
JOURNAL OF SURGICAL RESEARCH (2002)
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats
S Mirkovic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy
Y Kanzaki et al.
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION (2001)
Role of transforming growth factor-beta 1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis
M Koyanagi et al.
HYPERTENSION (2000)
分享论文
